Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction.

ABSTRACT:

Background

Patients with immune thrombocytopenic purpura (ITP) admitted with acute myocardial infarction (AMI) may be challenging to manage given their increased risk of bleeding complications. There is limited evidence in the literature guiding appropriate interventions in this population. The objective of this study is to determine the difference in clinical outcomes in AMI patients with and without ITP.

Methods

Using the United States national inpatient sample database, adults aged ≥18 years, who were hospitalized between 2007 and 2014 for AMI, were identified. Among those, patients with ITP were selected. A propensity-matched cohort analysis was performed. The primary outcome was in-hospital mortality. Secondary outcomes were coronary revascularization procedures, bleedi

SUBMITTER: Chehab O 

PROVIDER: S-EPMC6954382 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature